Michael J. LaBarre, SVP, Chief Technical Officer: Halozyme Therapeutics HALO Sell · Filed 23/02/17

Trade details

Type: Insider sale
Amount: $483,900
Shares · price: 10,000 sh · $48.39 a share
Held after: 143,477 sh
Stock: Halozyme Therapeutics HALO
Person: Michael J. LaBarreSVP, Chief Technical Officer
Trade date: 23/02/15
Filed: 23/02/17
Days to filing: 2 days

Sold 6.5% of holdings

Share of holding sold: 6.5%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/16~23/03/17

Michael J. LaBarre's recent trades

Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$546K
9,400 sh
$546K
Filed 25/02/27
Traded 25/02/26
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$539.5K
9,300 sh
$539.5K
Filed 25/02/27
Traded 25/02/25
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$93K
1,597 sh
$93K
Filed 25/02/27
Traded 25/02/27
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$41.1K
700 sh
$41.1K
Filed 25/02/27
Traded 25/02/25
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$35.2K
600 sh
$35.2K
Filed 25/02/27
Traded 25/02/26

Michael J. LaBarre, Chief Officer — sold $483.9K of Halozyme Therapeutics HALO · 6.5% of holdings | Whalegun